BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 25270048)

  • 21. Scaffold-based 3D cell culture models in cancer research.
    Abuwatfa WH; Pitt WG; Husseini GA
    J Biomed Sci; 2024 Jan; 31(1):7. PubMed ID: 38221607
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Zika Virus Infection Alters the Circadian Clock Expression in Human Neuronal Monolayer and Neurosphere Cultures.
    de Lima Cavalcanti TYV; Lima MC; Bargi-Souza P; Franca RFO; Peliciari-Garcia RA
    Cell Mol Neurobiol; 2023 Dec; 44(1):10. PubMed ID: 38141078
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Patient-derived organoid culture in epithelial ovarian cancers-Techniques, applications, and future perspectives.
    Chan WS; Mo X; Ip PPC; Tse KY
    Cancer Med; 2023 Oct; 12(19):19714-19731. PubMed ID: 37776168
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Magnetic force-based cell manipulation for
    Hu H; Krishaa L; Fong ELS
    APL Bioeng; 2023 Sep; 7(3):031504. PubMed ID: 37736016
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cancer 3D Models for Metallodrug Preclinical Testing.
    Engrácia DM; Pinto CIG; Mendes F
    Int J Mol Sci; 2023 Jul; 24(15):. PubMed ID: 37569291
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Stem cell-derived intestinal organoids: a novel modality for IBD.
    Tian CM; Yang MF; Xu HM; Zhu MZ; Yue NN; Zhang Y; Shi RY; Yao J; Wang LS; Liang YJ; Li DF
    Cell Death Discov; 2023 Jul; 9(1):255. PubMed ID: 37479716
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Replacement, Reduction, and Refinement of Animal Experiments in Anticancer Drug Development: The Contribution of 3D In Vitro Cancer Models in the Drug Efficacy Assessment.
    Tosca EM; Ronchi D; Facciolo D; Magni P
    Biomedicines; 2023 Mar; 11(4):. PubMed ID: 37189676
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Key aspects for conception and construction of co-culture models of tumor-stroma interactions.
    Mason J; Öhlund D
    Front Bioeng Biotechnol; 2023; 11():1150764. PubMed ID: 37091337
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cancer Spheroids and Organoids as Novel Tools for Research and Therapy: State of the Art and Challenges to Guide Precision Medicine.
    El Harane S; Zidi B; El Harane N; Krause KH; Matthes T; Preynat-Seauve O
    Cells; 2023 Mar; 12(7):. PubMed ID: 37048073
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment of 3D In Vitro Tumoroids of Ovarian Cancer Using Photochemical Internalisation as a Drug Delivery Method.
    Mohammad Hadi L; Stamati K; Yaghini E; MacRobert AJ; Loizidou M
    Biomedicines; 2023 Feb; 11(2):. PubMed ID: 36831108
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hyper-Branched Cationic Cyclodextrin Polymers for Improving Plasmid Transfection in 2D and 3D Spheroid Cells.
    Monfared YK; Mahmoudian M; Cecone C; Caldera F; Haiaty S; Heidari HR; Rahbarghazi R; Matencio A; Zakeri-Milani P; Trotta F
    Pharmaceutics; 2022 Dec; 14(12):. PubMed ID: 36559184
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Three-dimensional in vitro culture models in oncology research.
    Jubelin C; Muñoz-Garcia J; Griscom L; Cochonneau D; Ollivier E; Heymann MF; Vallette FM; Oliver L; Heymann D
    Cell Biosci; 2022 Sep; 12(1):155. PubMed ID: 36089610
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Three-Dimensional In Vitro Cell Culture Models for Efficient Drug Discovery: Progress So Far and Future Prospects.
    Badr-Eldin SM; Aldawsari HM; Kotta S; Deb PK; Venugopala KN
    Pharmaceuticals (Basel); 2022 Jul; 15(8):. PubMed ID: 36015074
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 3D Disease Modelling of Hard and Soft Cancer Using PHA-Based Scaffolds.
    Tomar A; Uysal-Onganer P; Basnett P; Pati U; Roy I
    Cancers (Basel); 2022 Jul; 14(14):. PubMed ID: 35884609
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Self-Assembled Peptide Habitats to Model Tumor Metastasis.
    Al Balushi N; Boyd-Moss M; Samarasinghe RM; Rifai A; Franks SJ; Firipis K; Long BM; Darby IA; Nisbet DR; Pouniotis D; Williams RJ
    Gels; 2022 May; 8(6):. PubMed ID: 35735676
    [TBL] [Abstract][Full Text] [Related]  

  • 36. TIMP-1-expressing breast tumor spheroids for the evaluation of drug penetration and efficacy.
    Bae IY; Choi W; Oh SJ; Kim C; Kim SH
    Bioeng Transl Med; 2022 May; 7(2):e10286. PubMed ID: 35600659
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Spatiotemporal Tracking of Different Cell Populations in Cancer Organoid Models for Investigations on Photodynamic Therapy.
    Bulin AL; Hasan T
    Methods Mol Biol; 2022; 2451():81-90. PubMed ID: 35505012
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nano to rescue: repository of nanocarriers for targeted drug delivery to curb breast cancer.
    Banthia P; Gambhir L; Sharma A; Daga D; Kapoor N; Chaudhary R; Sharma G
    3 Biotech; 2022 Mar; 12(3):70. PubMed ID: 35223356
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 3D Cell Culture Models as Recapitulators of the Tumor Microenvironment for the Screening of Anti-Cancer Drugs.
    Barbosa MAG; Xavier CPR; Pereira RF; Petrikaitė V; Vasconcelos MH
    Cancers (Basel); 2021 Dec; 14(1):. PubMed ID: 35008353
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 3D tumor angiogenesis models: recent advances and challenges.
    Bhat SM; Badiger VA; Vasishta S; Chakraborty J; Prasad S; Ghosh S; Joshi MB
    J Cancer Res Clin Oncol; 2021 Dec; 147(12):3477-3494. PubMed ID: 34613483
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.